← Leaderboards
Sara K Coulup
University Of Minnesota
$93,057
Attributed
$93,057
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $33.9K · FY2016–19$50K$37.5K$25K$12.5K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$93,057 · 1
By mechanism
F31$93,057 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Daniel A. Mulrooney$2,717,970
- Lucie Marie Turcotte$1,777,930
- Sergio A Gradilone$3,873,849
- Steven E Patterson$9,957,982
- Grace Elizabeth Pluhar$2,827,619
Others in their field
Top investigators on “Alpha Tubulin”
- David Heimbrook · Leidos Biomedical Research, Inc.$7,124,753
- Stuart C Sweet · Washington University$5,214,393
- Christopher William Ward · University Of Maryland Baltimore$4,612,171
- Martin Chalfie · Columbia Univ New York Morningside$4,164,138
- Jian Fu · University Of Texas Hlth Ctr At Tyler$3,825,000
- Francesca Bartolini · Columbia University Health Sciences$3,786,702
Research focus
Alpha TubulinAmerican Cancer SocietyAnalogAntibodiesAntibody-Drug ConjugatesAnti-Cancer TherapeuticAntineoplastic AgentsAntiproliferative AgentsAntitumor EffectBaseBehaviorBeta TubulinBindingBiochemicalBiological AvailabilityBody Weight DecreasedCancer CellCancer Cell LineCancer EtiologyCancer PatientCancer SurvivorCancer TherapyCell Cycle ProgressionCell Line
Grant awards (3)
Design and synthesis of stabilized pironetin analogs for the treatment of resistant ovarian cancers$33,935
F31 · FY2019 · CA · contact PI
Design and synthesis of stabilized pironetin analogs for the treatment of resistant ovarian cancers$29,795
F31 · FY2017 · CA · contact PI
Design and synthesis of stabilized pironetin analogs for the treatment of resistant ovarian cancers$29,327
F31 · FY2016 · CA · contact PI